Ann Tan
Impact in
- Otorhinolaryngology top 10%
- Head and Neck Cancer Studies
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Disease and Transplantation
Papers in
- Surgery 7
- Bladder and Urothelial Cancer Treatments 2
-
- Renal cell carcinoma treatment 4
- Co-authors
- Richard D. Kim (5 shared papers)Federico Aucejo (6 shared papers)Lisa Rybicki (2 shared papers)Richard Kim (2 shared papers)Bassel F. El‐Rayes (1 shared paper)Paul Elson (2 shared papers)Robert R. Lorenz (1 shared paper)David J. Adelstein (1 shared paper)
- Journals
- Journal of Clinical Oncology (2 papers)Oncology (2 papers)Cancer (1 paper)Current Oncology Reports (1 paper)ANZ Journal of Surgery (1 paper)
- Partner nations
- United StatesCanadaAustralia
In The Last Decade
Ann Tan
15 papers receiving 232 citations
Peers
Comparison fields: 5 of 42
- Otorhinolaryngology 50
- Hepatology 70
- Oncology 98
- Gastroenterology 16
- Surgery 95
Countries citing papers authored by Ann Tan
This map shows the geographic impact of Ann Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann Tan more than expected).
Fields of papers citing papers by Ann Tan
This network shows the impact of papers produced by Ann Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann Tan. The network helps show where Ann Tan may publish in the future.
Co-authors
The 25 scholars most cited alongside Ann Tan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 56 | |
| 2 | 2011 | 41 | |
| 3 | 2010 | 39 | |
| 4 | 2013 | 32 | |
| 5 | 2010 | 19 | |
| 6 | 2014 | 18 | |
| 7 | 2010 | 13 | |
| 8 | Adjuvant treatment after orthotopic liver transplantation: is it really necessary? | 2009 | 4 |
| 9 | 2008 | 3 | |
| 10 | 2008 | 3 | |
| 11 | Serum Vascular Endothelial Growth Factor Level in Patients with Hepatocellular Carcinoma Undergoing Liver Transplantation: Experience of a Single Western Center | 2012 | 2 |
| 12 | Serum vascular endothelial growth factor level in patients with hepatocellular carcinoma undergoing liver transplantation: experience of a single Western center. | 2012 | 2 |
| 13 | 2023 | 1 | |
| 14 | 2024 | 1 | |
| 15 | 2008 | 1 | |
| 16 | 2009 | 0 |
About Ann Tan
Ann Tan is a scholar working on Surgery, Pulmonary and Respiratory Medicine, Molecular Biology, Hepatology and Oncology, having authored 16 papers that have together received 235 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Renal cell carcinoma treatment (4 papers), Angiogenesis and VEGF in Cancer (4 papers), Bladder and Urothelial Cancer Treatments (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Pancreatic and Hepatic Oncology Research (2 papers), Liver Disease and Transplantation (2 papers) and Colorectal Cancer Treatments and Studies (1 paper). The work is most often cited by research in Otorhinolaryngology (50 citations), Hepatology (70 citations), Oncology (98 citations), Gastroenterology (16 citations) and Surgery (95 citations). Ann Tan has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include Richard D. Kim, Federico Aucejo, Lisa Rybicki, Richard Kim, Bassel F. El‐Rayes, Paul Elson, Robert R. Lorenz, David J. Adelstein, Galal El‐Gazzaz and Jerrold P. Saxton. Their work appears in journals such as Journal of Clinical Oncology, Oncology, Cancer, Current Oncology Reports and ANZ Journal of Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.